Peripheral signals conveying metabolic information to the brain: Short-term and long-term regulation of food intake and energy homeostasis

Experimental Biology and Medicine

Volumn 226, Issue 11, 2001, Pages 963-977

  Havel, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acylation stimulating protein; Adiponectin; Adipose tissue; Cholecystokinin; Gastrointestinal peptides; Ghrelin; Glucose; Insulin; Leptin

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; AMINO ACID; BOMBESIN; CHOLECYSTOKININ; COMPLEMENTARY DNA; CYTOKINE; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; GASTRIN RELEASING PEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HORMONE RECEPTOR; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN B; SOMATOMEDIN C; THYROID HORMONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL MODEL; CONFERENCE PAPER; DIETARY INTAKE; ENERGY BALANCE; FOOD INTAKE; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; IMMUNE SYSTEM; METABOLIC REGULATION; NONHUMAN; NUTRIENT; OBESITY; RAT;

ANIMALIA;

EID: 0035758109     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020122601102     Document Type: Conference Paper

References (230)

1. Bray GA. Weight homeostasis. Annu Rev Med 42:205-216, 1991.
2. Levin BE, Routh VH. Role of the brain in energy balance and obesity. Am J Physiol 271:R491-R500, 1996.
3. Keesey RE, Hirvonen MD. Body weight set-points: determination and adjustment. J Nutr 127:1875S-1883S, 1997.
4. Nishizawa Y, Bray GA. Evidence for a circulating ergostatic factor: studies on parabiotic rats. Am J Physiol 239:R344-R351, 1980.
5. Harris RB, Martin RJ. Specific depletion of body fat in parabiotic partners of tube-fed obese rats. Am J Physiol 247:R380-R386, 1984.
6. Mayer J. Glucostatic mechanism of regulation of food intake. N Engl J Med 249:13-16, 1953.
7. Bray GA. Static theories in a dynamic world: a glucodynamic theory of food intake. Obes Res 4:489-492, 1996.
8. Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 217:1083-1087, 1969.
9. Thompson DA, Campbell RG. Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science 198:1065-1068, 1977.
10. Oomura Y, Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 222:282-284, 1969.
11. Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213:451-452, 1981.
12. Novin D, VanderWeele DA, Rezek M. Infusion of 2-deoxy-D-glucose into the hepatic-portal system causes eating: evidence for peripheral glucoreceptors. Science 181:858-860, 1973.
13. Bergen HT, Monkman N, Mobbs CV. Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucose-responsive neurons are important for long-term regulation of body weight. Brain Res 734:332-336, 1996.
14. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor: similarities to and differences from pancreatic β cell mechanisms. Diabetes 48:1763-1772, 1999.
15. Woods SC, Stein LJ, McKay LD, Porte D Jr. Suppression of food intake by intravenous nutrients and insulin in the baboon. Am J Physiol 247:R393-R401, 1984.
16. Novin D, Robinson K, Culbreth LA, Tordoff MG. Is there a role for the liver in the control of food intake? Am J Clin Nutr 42(Suppl 5):1050-1062, 1985.
17. Nicolaidis S, Even PC. The ischymetric control of feeding. Int J Obes 14(Suppl 3):35-49; discussion 50-52, 1990.
18. Campfield LA, Smith FJ. Transient declines in blood glucose signal meal initiation. Int J Obes 14(Suppl 3):15-31; discussion 31-34. 1990.
19. Smith FJ, Driscoll DW, Campfield LA. Short-term effects of fructose on blood glucose dynamics and meal initiation. Physiol Behav 44:625-631, 1988.
20. Campfield LA, Smith FJ, Rosenbaum M. Human hunger: is there a role for blood glucose dynamics? Appetite 18:244, 1992.
21. Mellinkoff SM, Franklund M, Bouyle D, Greipel M. Relationships between serum amino acid concentration and fluctuations in appetite. J Appl Physiol 8:535-538, 1956.
22. Bray GA. Amino acids, protein, and body weight. Obes Res 5:373-376, 1997.
23. Porrini M, Santangelo A, Crovetti R, Riso P, Testolin G, Blundell JE. Weight, protein, fat, and timing of preloads affect food intake. Physiol Behav 62:563-570, 1997.
24. Gibson EL, Wainwright CJ, Booth DA. Disguised protein in lunch after low-protein breakfast conditions food-flavor preferences dependent on recent lack of protein intake. Physiol Behav 58:363-371, 1995.
25. Rogers PJ, Blundell JE. Reanalysis of the effects of phenylalanine, alanine, and aspartame on food intake in human subjects. Physiol Behav 56:247-250, 1994.
26. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149-152, 1971.
27. Gietzen DW. Neural mechanisms in the responses to amino acid deficiency. J Nutr 123:610-625, 1993.
28. Niijima A, Meguid MM. An electrophysiological study on amino acid sensors in the hepatoportal system in the rat. Obes Res 3(Suppl 5):741S-745S, 1995.
29. Fisler JS, Egawa M, Bray GA. Peripheral 3-hydroxybutyrate and food intake in a model of dietary fat-induced obesity: effect of vagotomy. Physiol Behav 58:1-7, 1995.
30. Ritter S, Ritter JB, Cromer L. 2-Deoxy-D-glucose and mercaptoacetate induce different patterns of macronutrient ingestion. Physiol Behav 66:709-715, 1999.
31. Sergeyev V, Broberger C, Gorbatyuk O, Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 11:117-121, 2000.
32. Friedman MI, Harris RB, Ji H, Ramirez I, Tordoff MG. Fatty acid oxidation affects food intake by altering hepatic energy status. Am J Physiol 276:R1046-R1053, 1999.
33. Pardridge WM, Mietus LJ. Palmitate and cholesterol transport through the blood-brain barrier. J Neurochem 34:463-466, 1980.
34. Kasser TR, Harris RB, Martin RJ. Level of satiety: fatty acid and glucose metabolism in three brain sites associated with feeding. Am J Physiol 248:R447-R452, 1985.
35. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:2379-2381, 2000.
36. Makimura H, Mizuno TM, Yang XJ, Silverstein J, Beasley J, Mobbs CV. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50:733-739, 2001.
37. Tso P, Liu M, Kalogeris TJ. The role of apolipoprotein A-IV in food intake regulation. J Nutr 129:1503-1506, 1999.
38. Liu M, Doi T, Shen L, Woods SC, Seeley RJ, Zheng S, Jackman A, Tso P. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am J Physiol 280:R1382-R1387, 2000.
39. Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO. Fat and carbohydrate overfeeding: different effects on energy storage. Am J Clin Nutr 62:19-29, 1995.
40. Tremblay A, Plourde G, Despres JP, Bouchard C. Impact of dietary fat content and fat oxidation on energy intake in humans. Am J Clin Nutr 49:799-805, 1998.
41. Tataranni PA, Ravussin E. Effect of fat intake on energy balance. Ann N Y Acad Sci 819:37-43, 1997.
42. Hill JO, Lin D, Yakubu F, Peters JC. Development of dietary obesity in rats: influence of amount and composition of dietary fat. Int J Obes 16:321-333, 1992.
43. Nagase H, Bray GA, York DA. Effects of pyruvate and lactate on food intake in rat strains sensitive and resistant to dietary obesity. Physiol Behav 59:555-560, 1996.
44. Havel PJ, Townsend R, Chaump L, Teff K. High-fat meals reduce 24-h circulating leptin concentrations in women. Diabetes 48:334-341, 1999.
45. Freedman MR, King JC, Kennedy E. Popular Diets: a scientific review. Obes Res 9(Suppl 1):1S-40S, 2001.
46. Rolls BJ, Bell EA. Intake of fat and carbohydrate: role of energy density. Eur J Clin Nutr 53(Suppl 1):S166-S173, 1999.
47. Adolph, EF. Urges to eat and drink in rats. Am J Physiol 151:641-646, 1947.
48. Smith M, Duffy M. The effects of intragastric injection of various substances on subsequent bar pressing. J Comp Physiol Psychol 49:553-557, 1955.
49. Stubbs J, Ferres S, Horgan G. Energy density of foods: effects on energy intake. Crit Rev Food Sci Nutr 40:481-515, 2000.
50. Bray GA. Nutrient intake is modulated by peripheral peptide administration. Obes Res 3(Suppl 4):569S-572S, 1995.
51. Smith GP, Gibbs J. Satiating effect of cholecystokinin. Ann N Y Acad Sci 713:236-241, 1994.
52. Moran TH. Cholecystokinin and satiety: current perspectives. Nutrition 16:858-865, 2000.
53. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84:488-495, 1973.
54. Metzger BL, Hansen BC. Cholecystokinin effects on feeding, glucose. and pancreatic hormones in rhesus monkeys. Physiol Behav 30:509-518, 1983.
55. Stein LJ, Porte D Jr., Figlewicz DP, Woods SC. Effect of fasting interval on CCK-8 suppression of food intake in the baboon. Am J Physiol 250:R851-R855, 1986.
56. Pi-Sunyer X, Kissileff HR, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in obese men. Physiol Behav 29:627-630, 1982.
57. Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol 262:R975-R980, 1992.
58. Miesner J, Smith GP, Gibbs J, Tyrka A. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats. Am J Physiol 262:R216-R219, 1992.
59. Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46-R50, 1992.
60. Moran TH, Ameglio PJ, Peyton HJ, Schwartz GJ, McHugh PR. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 265:R620-R624, 1993.
61. Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274:R618-R625, 1998.
62. Takiguchi S, Takata Y, Takahashi N, Kataoka K, Hirashima T, Kawano K, Miyasaka K, Funakoshi A, Kono A. A disrupted cholecystokinin A receptor gene induces diabetes in obese rats synergistically with ODB1 gene. Am J Physiol 274:E265-E270, 1998.
63. Tachibana I, Akiyama T, Kanagawa K, Shiohara H, Furumi K, Watanabe N, Otsuki M. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats. Am J Physiol 270:G730-G737, 1996.
64. Liddle RA, Morita ET, Conrad CK, Williams JA. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 77:992-996, 1986.
65. Muurahainen N, Kissileff HR, Derogatis AJ, Pi-Sunyer FX. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol Behav 44:645-649, 1988.
66. Beinfeld MC. Cholecystokinin in the central nervous system: a minireview. Neuropeptides 3:411-427, 1983.
67. Schick RR, Reilly WM, Roddy DR, Yaksh TL, Go VL. Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain Res 418:20-26, 1987.
68. De Fanti BA, Backus RC, Hamilton JS, Gietzen DW, Horwitz BA. Lean (Fa/Fa) but not obese (fa/fa) Zucker rats release cholecystokinin at PVN after a gavaged meal. Am J Physiol 275:E1-E5, 1998.
69. Figlewicz DP, Sipols AJ, Porte D Jr., Woods SC, Liddle RA. Intraventricular CCK inhibits food intake and gastric emptying in baboons. Am J Physiol 256:R1313-R1317, 1989.
70. Figlewicz DP, Sipols AJ, Green P, Porte D Jr., Woods SC. IVT CCK-8 is more effective than IV CCK-8 at decreasing meal size in the baboon. Brain Res Bull 22:849-852, 1989.
71. Figlewicz DP, Nadzan AM, Sipols AJ, Green PK, Liddle RA, Porte D Jr., Woods SC. Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. Am J Physiol 263:R863-867, 1992.
72. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302:703-706, 1983.
73. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 246:R776-R787, 1984.
74. Drucker DJ. Glucagon-like peptides. Diabetes 47:159-169, 1998.
75. Balks HJ, Holst JJ, von zur Muhlen A, Brabant G. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab 82:786-790, 1997.
76. D'Alessio DA, Kieffer TJ, Taborsky GJ Jr., Havel PJ. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 86:1253-1259, 2001.
77. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515-520, 1998.
78. Naslund E, Gutniak M, Skogar S, Rossner S, Hellstrom PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 68:525-530, 1998.
79. Schirra J, Leicht P, Hildebrand P, Beglinger C, Arnold R, Goke B, Katschinski M. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. J Endocrinol 156:177-186, 1998.
80. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72, 1996.
81. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848-R856, 1996.
82. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140:244-250, 1999.
83. Merali Z, McIntosh J, Anisman H. Role of bombesin-related peptides in the control of food intake. Neuropeptides 33:376-386, 1999.
84. Figlewicz DP, Stein LJ, Woods SC, Porte D Jr. Acute and chronic gastrin-releasing peptide decreases food intake in baboons. Am J Physiol 248:R578-R583, 1985.
85. Gutzwiller JP, Drewe J, Hildebrand P, Rossi L, Lauper JZ, Beglinger C. Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology 106:1168-1173, 1994.
86. Yegen BC, Gurbuz V, Coskun T, Bozkurt A, Kurtel H, Alican I, Dockray GJ. Inhibitory effects of gastrin releasing peptide on gastric emptying in rats. Regul Pept 61:175-180, 1996.
87. Figlewicz DP, Sipols A, Porte D Jr., Woods SC. Intraventricular bombesin can decrease single meal size in the baboon. Brain Res Bull 17:535-537, 1986.
88. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999.
89. Bowers CY. Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab 86:1464-1469, 2001.
90. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122, 2001.
91. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409:194-198, 2001.
92. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000.
93. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709, 2001.
94. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328, 2000.
95. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227-232, 2001.
96. Bray GA. Nutrient intake is modulated by peripheral peptide administration. Obes Res 3(Suppl 4):569S-572S, 1995.
97. Hirschberg AL. Hormonal regulation of appetite and food intake. Ann Med 30:7-20, 1998.
98. Havel PJ, Taborsky GJ Jr. The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocrinol Rev 10:332-350, 1989.
99. Geary N, Asarian L, Langhans W. The satiating potency of hepatic portal glucagon in rats is not affected by [corrected] insulin or insulin antibodies. Physiol Behav 61:199-208, 1997.
100. Shimizu H, Egawa M, Yoshimatsu H, Bray GA. Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monoamine metabolism. Brain Res 630:95-100, 1993.
101. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 14:497-503, 1993.
102. Liu M, Shen L, Tso P. The role of enterostatin and apolipoprotein AIV on the control of food intake. Neuropeptides 33:425-433, 1999.
103. Erlanson-Albertsson C, York D. Enterostatin: a peptide regulating fat intake. Obes Res 5:360-372, 1997.
104. Lotter EC, Krinsky R, McKay JM, Treneer CM, Porter D Jr., Woods SC. Somatostatin decreases food intake of rats and baboons. J Comp Physiol Psychol 95:278-287, 1981.
105. Lieverse RJ, Jansen JB, Masclee AM, Lamers CB. Effects of somatostatin on human satiety. Neuroendocrinology 61:112-116, 1995.
106. Arnelo U, Permert J, Larsson J, Reidelberger RD, Arnelo C, Adrian TE. Chronic low-dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique. Endocrinology 138:4081-4085, 1997.
107. Lutz TA, Rossi R, Althaus J, Del Prete E, Scharrer E. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides 19:1533-1540, 1998.
108. Lavin JH, Wittert GA, Andrews J, Yeap B, Wishart JM, Morris HA, Morley JE, Horowitz M, Read NW. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. Am J Clin Nutr 68:591-598, 1998.
109. Plata-Salaman CR. Cytokines and feeding suppression: an integrative view from neurologic to molecular levels. Nutrition 11(Suppl 5):674-677, 1995.
110. Schwartz MW, Seeley RJ, Woods SC. Wasting illness as a disorder of body weight regulation. Proc Nutr Soc 56:785-791, 1997.
111. Weingarten HP. Cytokines and food intake: the relevance of the immune system to the student of ingestive behavior. Neurosci Biobehav Rev 20:163-170, 1996.
112. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994.
113. Finck BN, Johnson RW. Tumor necrosis factor-α regulates secretion of the adipocyte-derived cytokine, leptin. Microsci Res Technol 50:209-215, 2000.
114. Medina EA, Stanhope KL, Mizuno TM, Mobbs CV, Gregoire F, Hubbard NE, Erickson KL, Havel PJ. Effects of tumor necrosis factor-α on leptin secretion and gene expression: relationship to changes of glucose metabolism in isolated rat adipocytes. Int J Obes Relat Metab Disord 23:896-903, 1999.
115. Dallman MF, Akana SF, Strack AM, Hanson ES, Sebastian RJ. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann N Y Acad Sci 771:730-742, 1995.
116. Tempel DL, McEwen BS, Leibowitz SF. Effects of adrenal steroid agonists on food intake and macronutrient selection. Physiol Behav 52:1161-1166, 1992.
117. Strack AM, Sebastian RJ, Schwartz MW, Dallman MF. Glucocorticoids and insulin: reciprocal signals for energy balance. Am J Physiol 268:R142-R149, 1995.
118. Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol 271:E317-E325, 1996.
119. Widjaja A, Schurmeyer TH, Von zur Muhlen A, Brabant G. Determinants of serum leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 83:600-603, 1998.
120. Chavez M, Seeley RJ, Green PK, Wilkinson CW, Schwartz MW, Woods SC. Adrenalectomy increases sensitivity to central insulin. Physiol Behav 62:631-634, 1997.
121. Baura GD, Foster DM, Kaiyala K, Porte D Jr., Kahn SE, Schwartz MW. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45:86-90, 1996.
122. York DA. Lessons from animal models of obesity. Endocrinol Metab Clin North Am 25:781-800, 1996.
123. Lin MT, Chu PC, Leu SY. Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat. Neuroendocrinology 37:206-211, 1983.
124. Foster LA, Ames NK, Emery RS. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-1. Physiol Behav 50:745-749, 1991.
125. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T, Wakabayashi I. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137:5155-5158, 1996.
126. Tanaka Y, Egawa M, Inoue S, Takamura Y. Effect of hypothalamic administration of growth hormone-releasing factor (GRF) on feeding behavior in rats. Brain Res 558:273-279, 1991.
127. Woods SC, Decke E, Vasselli JR. Metabolic hormones and regulation of body weight. Psychol Rev 81:26-43, 1974.
128. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocrinol Rev 13:387-414, 1992.
129. Woods SC, Chavez M, Park CR, Riedy C, Kaiyala K, Richardson RD, Figlewicz DP, Schwartz MW, Porte D Jr., Seeley RJ. The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev 20:139-144, 1996.
130. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB. Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100:398-403, 1997.
131. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM. Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11:107-111, 1988.
132. Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ Jr., Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D Jr. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs: quantitative aspects and implications for transport. J Clin Invest 88:1272-1281, 1991.
133. Woods SC, Lotter EC, McKay LD, Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282:503-505, 1979.
134. Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404:661-671, 2000.
135. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 69:584-596, 1999.
136. Sipols AJ, Baskin DG, Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44:147-151, 1995.
137. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125, 2000.
138. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93:2365-2371, 1994.
139. Diamond P, LeBlanc J. A role for insulin in cephalic phase of postprandial thermogenesis in dogs. Am J Physiol 254:E625-E632, 1988.
140. Figlewicz DP, Stein LJ, West D, Porte D Jr., Woods SC. Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons. Am J Physiol 250:R856-R860, 1986.
141. Figlewicz DP, Sipols AJ, Seeley RJ, Chavez M, Woods SC, Porte D Jr. Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. Behav Neurosci 109:567-569, 1995.
142. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 80:1571-1576, 1995.
143. Gerozissis K, Rouch C, Nicolaidis S, Orosco M. Brain insulin response to feeding in the rat is both macronutrient and area specific. Physiol Behav 66:271-275, 1999.
144. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49:1525-1533, 2000.
145. Kennedy AG. The role of the fat depot in the hypothalamic control of food intake in the rat. Proc Roy Soc Lond B Biol Sci 140:578-592, 1953.
146. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217:1298-1304, 1969.
147. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9:294-298, 173.
148. Wilson BE, Meyer GE, Cleveland JC Jr., Weigle DS. Identification of candidate genes for a factor regulating body weight in primates. Am J Physiol 259:R1148-R1155, 1990.
149. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994.
150. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriary A, Moore KJ, Smutko JS, Mays GC, Woolf EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995.
151. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495, 1996.
152. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994-996, 1996.
153. Tartaglia LA. The leptin receptor. J Biol Chem 272:6093-6096, 1997.
154. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 45:1455-1462, 1996.
155. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 59:359-371, 2000.
156. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 93:1726-1730, 1996.
157. Scarpace PJ, Matheny M, Pollock BH, Tumer N. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 273:E226-E220, 1997.
158. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 380:677, 1996.
159. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270-278, 1997.
160. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab 84:711-717, 1999.
161. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997.
162. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18:213-215, 1998.
163. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401, 1998.
164. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884, 1999.
165. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. J Am Med Assoc 282:1568-1575, 1999.
166. Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 85:4003-4009, 2000.
167. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2:589-593, 1996.
168. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996.
169. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274:30059-30065, 1999.
170. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832, 2000.
171. Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 68:794-801, 1998.
172. McMinn JE, Sindelar DK, Havel PJ, Schwartz MW. Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 141:4442-4448, 2000.
173. Matson CA, Wiater MF, Kuijper JL, Weigle DS. Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 18:1275-1278, 1997.
174. Matson CA, Ritter RC. Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight. Am J Physiol 276:R1038-R1045, 1999.
175. Emond M, Schwartz GJ, Ladenheim EE, Moran TH. Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol 276:R1545-R1549, 1999.
176. Matson CA, Reid DF, Cannon TA, Ritter RC. Cholecystokinin and leptin act synergistically to reduce body weight. Am J Physiol 278:R882-R890, 2000.
177. Wang L, Barachina MD, Martinez V, Wei JY, Tache Y. Synergistic interaction between CCK and leptin to regulate food intake. Regul Pept 92:79-85, 2000.
178. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995.
179. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996.
180. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 81:4406-4413, 1996.
181. Ahren B, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol 273:R113-R120, 1997.
182. Landt M, Gingerich RL, Havel PJ, Mueller WM, Schoner B, Hale JE, Heiman ML. Radioimmunoassay of rat leptin: sexual dimorphism reversed from humans. Clin Chem 44:565-570, 1998.
183. Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL, Houmard JA, Marks RH, Caro JF. Gender differences in serum leptin levels in humans. Biochem Mol Med 59:1-6, 1996.
184. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nat Med 2:949-950, 1996.
185. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419-3423, 1996.
186. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82:561-565, 1997.
187. Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47:429-434, 1998.
188. Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45:1511-1515, 1996.
189. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 81:4162-4165, 1996.
190. Havel PJ. Glucose, but not fructose, infusion increases circulating leptin in proportion to adipose stores in rhesus monkeys. Exp Clin Endocrinol Metab 105(Suppl 3):37-38, 1997.
191. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes 45:1364-1366, 1996.
192. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544-549, 1998.
193. Wisse BE, Campfield LA, Marliss EB, Morais JA, Tenenbaum R, Gougeon R. Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women. Am J Clin Nutr 70:321-330, 1999.
194. Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol 274: R1482-R1491, 1998.
195. Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 49:244-252, 2000.
196. Sindelar DK, Havel PJ, Seeley RJ, Wilkinson CW, Woods SC, Schwartz MW. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 48:1275-1280, 1999.
197. Figlewicz DP Higgins MS, Ng-Evans SB, Havel PJ. Leptin reverses sucrose-conditioned place preference in food-restricted rats. Physiol Behav 73:229-234, 2001.
198. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139:551-558, 1998.
199. Moreno-Aliaga MJ, Stanhope KL, Havel PJ. Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3T3-L1 adipocytes. Biochem Biophys Res Commun 283:544-548, 2001.
200. Mueller WM, Stanhope KL, Gregoire F, Evans JL, Havel PJ. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 8:530-539, 2000.
201. Havel PJ, Stanhope KL, Moreno-Aliaga MJ, Kras KM, Evans J. Potential role for mitochondrial metabolism in regulating leptin production by cultured rat adipocytes. Obes Res 7:63S, 1999.
202. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF. Nocturnal rise of leptin in lean, obese, and non-insulin-diabetes mellitus subjects. J Clin Invest 97:1344-1347, 1996.
203. Schoeller DA, Cella LK, Sinha MK, Caro JF. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 100:1882-1887, 1997.
204. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW. Robust leptin secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab 82:3230-2333, 1997.
205. Laferrere B, Fried SK, Hough K, Campbell SA, Thornton J, PiSunyer FX. Synergistic effects of feeding and dexamethasone on serum leptin levels. J Clin Endocrinol Metab 83:3742-3745, 1998.
206. Purnell JQ, Samuels MH. Levels of leptin during hydrocortisone infusions that mimic normal and reversed diurnal cortisol levels in subjects with adrenal insufficiency. J Clin Endocrinol Metab 84:3125-3128, 1999.
207. Boden G, Chen X, Urbain JL. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 45:1044-1050, 1996.
208. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100:1107-1113, 1997.
209. Wellhoener P, Fruehwald-Schultes B, Kern W, Dantz D, Kerner W, Born J, Fehm HL, Peters A. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 85:1267-1271, 2000.
210. Curry DL. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 4:2-9, 1989.
211. Elliott S, Teff K, Townsend R, Havel PJ. Consuming high-fructose meals reduces postprandial and 24 hour circulating insulin and leptin concentrations in women. Diabetes 50(Suppl 2):A532, 2001.
212. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357:505-508, 2001.
213. Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol 10:31-41, 1999.
214. Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol 11:291-296, 2000.
215. Murray I, Sniderman AD, Havel PJ, Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 274:36219-36225, 1999.
216. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141:1041-1049, 2000.
217. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25:87-90, 2000.
218. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, Chan L. Absence of perilipin results in leanness and reverses obesity in Lepr (db/db) mice. Nat Genet 26:474-479, 2000.
219. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494-6499, 2001.
220. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289, 1996.
221. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999.
222. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749, 1995.
223. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703, 1996.
224. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133, 2001.
225. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001.
226. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005-2010, 2001.
227. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-2616, 2001.
228. Anand A, Chada K. In vivo modulation of Hmgic reduces obesity. Nat Genet 24:377-380, 2000.
229. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001.
230. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr., Willson TM, Kliewer SA, Hotamisligil GS. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by PPARγ agonists. J Biol Chem 276:25651-25653, 2001.